» Authors » Munazza Ahmed

Munazza Ahmed

Explore the profile of Munazza Ahmed including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 81
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Semreen A, Oyoun Alsoud L, Semreen M, Ahmed M, Al-Hroub H, El-Awady R, et al.
Heliyon . 2024 Nov; 10(21):e39420. PMID: 39524752
Glioblastoma (GBM) stands as the most common primary malignant brain tumor. Despite the best standard therapies, GBM survivors have a brief survival time, about 24 months on average. The treatment...
2.
Kharaba Z, Alfoteih Y, Jirjees F, Albarbandi M, Hussain Z, Al Obaidi H, et al.
Sci Rep . 2024 Jul; 14(1):15426. PMID: 38965262
Stroke is a global public health concern, contributing to high rates of morbidity and mortality. In Syria, the current conflict and associated challenges have had a profound impact on healthcare...
3.
Eltayib E, Jirjees F, Suliman D, AlObaidi H, Ahmed M, Kharaba Z, et al.
Front Public Health . 2024 May; 12:1362979. PMID: 38774053
Introduction: Stroke, a leading cause of morbidity and mortality globally, demands heightened awareness and knowledge for effective preventive strategies and tailored response. Sudan is classified as a low income country...
4.
Ahmed M, Semreen A, Giddey A, Ramadan W, El-Awady R, Soares N, et al.
Ann Med . 2024 Jan; 55(2):2305308. PMID: 38253025
Background: Glioblastoma (GBM) is a primary malignancy of the central nervous system and is classified as a grade IV astrocytoma by the World Health Organization (WHO). Although GBM rarely metastasizes,...
5.
Alsabbagh R, Ahmed M, Alqudah M, Hamoudi R, Harati R
Cancers (Basel) . 2023 May; 15(8). PMID: 37190188
Brain metastasis is an incurable end-stage of systemic cancer associated with poor prognosis, and its incidence is increasing. Brain metastasis occurs through a multi-step cascade where cancer cells spread from...
6.
Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R
Pharmaceuticals (Basel) . 2023 Apr; 16(4). PMID: 37111328
Drug delivery to the central nervous system (CNS) is limited due to the presence of the blood-brain barrier (BBB), a selective physiological barrier located at the brain microvessels that regulates...
7.
Ahmed M, Semreen A, El-Huneidi W, Bustanji Y, Abu-Gharbieh E, Alqudah M, et al.
Int J Mol Sci . 2023 Jan; 24(1). PMID: 36613792
Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research, several aspects about the...
8.
Semreen A, Oyoun Alsoud L, El-Huneidi W, Ahmed M, Bustanji Y, Abu-Gharbieh E, et al.
Int J Mol Sci . 2022 Nov; 23(22). PMID: 36430415
Cancer of the central nervous system (CNS) is ranked as the 19th most prevalent form of the disease in 2020. This study aims to identify candidate biomarkers and metabolic pathways...
9.
Alchakee A, Ahmed M, Eldohaji L, Alhaj H, Saber-Ayad M
Int J Mol Sci . 2022 Nov; 23(21). PMID: 36362270
The activity of cytochrome P450 enzymes is influenced by genetic and nongenetic factors; hence, the metabolism of exogenous psychotropic medications and potentially some endogenous neuropeptides is variably affected among different...
10.
Hammash D, Mahfood M, Khoder G, Ahmed M, Tlili A, Hamoudi R, et al.
Breast Cancer (Dove Med Press) . 2022 Aug; 14:187-198. PMID: 35936987
Background: Most breast cancer-related deaths result from metastasis. Understanding the molecular basis of metastasis is needed for the development of effective targeted and preventive strategies. Matrix metalloproteinase-1 (MMP1) plays an...